Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00230269 · ClinicalTrials.gov registry record
The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 5
- Enrollment target
NCT00230269: Completed study, sponsored by Stanford University.
NCT00230269 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00230269 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
In patients with cancer of the head and neck and rectum, knowing the exact location of the tumor is important for designing the radiation field to ensure delivery of high dose of radiation to the tumor while sparing surrounding normal tissues. A new medical imaging method which is a combination of positron emission tomography (PET) and computed tomography (CT) scan, has shown promise in helping the radiation oncologist in defining the exact location and extent of the tumor in certain cancers such as lung cancers. Therefore the purpose of this study is to determine if these imaging methods can be used in combination with the standard radiation treatment planning procedure to improve the accuracy to targeting your tumor with radiation. In addition the PET-CT scan, similar to the PET scan alone with better resolution, can be used to determine whether the tumor has spread to any part of the body outside of the head and neck sites.
Interventions
- PROCEDURE PET-CT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2003-05 |
| Est. Completion | 2007-11 |
What the finished NCT00230269 record still lists
NCT00230269 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 5 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which PET-CT is the first listed.
NCT00230269 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00230269 about?
NCT00230269 is a clinical study titled "The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers". In patients with cancer of the head and neck and rectum, knowing the exact location of the tumor is important for designing the radiation field to ensure delivery of high dose of radiation to the tumor while sparing surrounding normal tissues. A new medical imaging method which is a combination of p...
What is the current status of trial NCT00230269?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2003-05. Estimated completion is 2007-11.
What interventions are being tested in trial NCT00230269?
The interventions under investigation include: PET-CT (PROCEDURE).
Who is sponsoring clinical trial NCT00230269?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia